127 related articles for article (PubMed ID: 7509061)
1. Effect of intraduodenal bile and taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of vasoactive intestinal polypeptide and somatostatin in man.
Riepl RL; Fiedler F; Teufel J; Lehnert P
Pancreas; 1994 Jan; 9(1):109-16. PubMed ID: 7509061
[TBL] [Abstract][Full Text] [Related]
2. Mediators of exocrine pancreatic secretion induced by intraduodenal application of bile and taurodeoxycholate in man.
Riepl RL; Reichardt B; Rauscher J; Tzavella K; Teufel J; Lehnert P
Eur J Med Res; 1997 Jan; 2(1):23-9. PubMed ID: 9049590
[TBL] [Abstract][Full Text] [Related]
3. Na-taurodeoxycholate acts as a specific intestinal stimulus of exocrine pancreatic secretion in man.
Lehnert P; Hempen I; Fiedler F; Hotz E; Danzl C; Mitra H; Riepl R
Scand J Gastroenterol Suppl; 1987; 139():14-9. PubMed ID: 2448866
[TBL] [Abstract][Full Text] [Related]
4. Effect of intraduodenal bile and Na- taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of secretin, pancreatic polypeptide, and gastrin in man.
Riepl RL; Lehnert P; Scharl A; Hempen I; Fiedler F; Teufel J; Burhol PG
Scand J Gastroenterol; 1990 Jan; 25(1):45-53. PubMed ID: 2305205
[TBL] [Abstract][Full Text] [Related]
5. Exocrine pancreatic secretion and plasma levels of cholecystokinin, pancreatic polypeptide, and somatostatin after single and combined intraduodenal application of different bile salts in man.
Riepl RL; Fiedler F; Kowalski C; Teufel J; Lehnert P
Ital J Gastroenterol; 1996; 28(8):421-9. PubMed ID: 9032583
[TBL] [Abstract][Full Text] [Related]
6. Effect of intraduodenal taurodeoxycholate and L-phenylalanine on pancreatic secretion and on gastroenteropancreatic peptide release in man.
Riepl RL; Fiedler F; Ernstberger M; Teufel J; Lehnert P
Eur J Med Res; 1996 Sep; 1(11):499-505. PubMed ID: 9438149
[TBL] [Abstract][Full Text] [Related]
7. Exocrine pancreatic secretion and immunoreactive secretin release after repeated intraduodenal infusions of bile in man.
Osnes M; Hanssen LE; Lehnert P; Flaten O; Larsen S; Londong W; Otte M
Scand J Gastroenterol; 1980; 15(8):1033-9. PubMed ID: 6165067
[TBL] [Abstract][Full Text] [Related]
8. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
[TBL] [Abstract][Full Text] [Related]
9. The influence of intraduodenal administration of pancreatic juice on the bile-induced pancreatic secretion and immunoreactive secretin release in man.
Osnes M; Hanssen LE
Scand J Gastroenterol; 1980; 15(8):1041-7. PubMed ID: 6165068
[TBL] [Abstract][Full Text] [Related]
10. The mediators of bile action on the exocrine pancreas.
Riepl RL; Lehnert P
Scand J Gastroenterol; 1993 May; 28(5):369-74. PubMed ID: 8099758
[TBL] [Abstract][Full Text] [Related]
11. Relationship between intravenous ethanol, alcohol-induced inhibition of pancreatic secretion and plasma concentration of immunoreactive pancreatic polypeptide, vasoactive intestinal peptide, and somatostatin in man.
Staub JL; Sarles H; Chayvialle JA; Descos F; Lassmann V; Vague P
Regul Pept; 1981 Apr; 2(1):61-8. PubMed ID: 6112782
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
Shiratori K; Watanabe S; Takeuchi T
Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
[TBL] [Abstract][Full Text] [Related]
13. The effect of duodenal infusion of bile on plasma VIP, GIP, and secretin and on duodenal bicarbonate secretion.
Burhol PG; Lygren I; Waldum HL; Jorde R
Scand J Gastroenterol; 1980; 15(8):1007-11. PubMed ID: 7233065
[TBL] [Abstract][Full Text] [Related]
14. Dose-response effect of intraduodenal HCl on exocrine pancreatic secretion, portal secretin, and VIP plasma levels in anesthetized rats.
García LJ; Minguela A; Calvo JJ; López MA
Arch Int Physiol Biochim Biophys; 1993; 101(3):167-71. PubMed ID: 7691208
[TBL] [Abstract][Full Text] [Related]
15. Effect of a new somatostatin analogue on pancreatic function in healthy volunteers.
Köhler E; Beglinger C; Dettwiler S; Whitehouse I; Gyr K
Pancreas; 1986; 1(2):154-9. PubMed ID: 2437563
[TBL] [Abstract][Full Text] [Related]
16. A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man.
Vatn MH; Schrumpf E; Hanssen KF; Myren J
J Endocrinol Invest; 1980; 3(3):279-82. PubMed ID: 6159391
[TBL] [Abstract][Full Text] [Related]
17. Bile secretion in man. The effects of somatostatin, vasoactive intestinal peptide and secretin.
Nyberg B
Acta Chir Scand Suppl; 1990; 557():1-40. PubMed ID: 1981635
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion.
Konturek SJ; Pucher A; Radecki T
J Physiol; 1976 Feb; 255(2):497-509. PubMed ID: 1255530
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat.
Alonso RM; Rodríguez AM; García LJ; López MA; Calvo JJ
Pancreas; 1994 Jan; 9(1):123-8. PubMed ID: 7509062
[TBL] [Abstract][Full Text] [Related]
20. Effect of intraduodenal sodium bicarbonate in rat and rabbit exocrine pancreatic secretion.
García LJ; Calvo JJ; Minguela A; López MA
Rev Esp Fisiol; 1992 Dec; 48(4):285-9. PubMed ID: 1338883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
